{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:07:40Z","timestamp":1785863260168,"version":"3.56.0"},"reference-count":10,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0238196","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T17:30:29Z","timestamp":1598376629000},"page":"e0238196","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-6344","authenticated-orcid":true,"given":"Michael S.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Niemuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Sabourin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Badorrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callie E.","family":"Bounds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8801-8744","authenticated-orcid":true,"given":"Thomas L.","family":"Rudge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"issue":"15","key":"pone.0238196.ref001","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of Zaire Ebola virus disease in Guinea","volume":"371","author":"S Baize","year":"2014","journal-title":"The New England journal of medicine"},{"issue":"11","key":"pone.0238196.ref002","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.3390\/v6114760","article-title":"Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014","volume":"6","author":"JH Kuhn","year":"2014","journal-title":"Viruses"},{"issue":"6202","key":"pone.0238196.ref003","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1126\/science.1259657","article-title":"Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak","volume":"345","author":"SK Gire","year":"2014","journal-title":"Science (New York, NY)"},{"issue":"1","key":"pone.0238196.ref004","doi-asserted-by":"crossref","first-page":"e1006037","DOI":"10.1371\/journal.ppat.1006037","article-title":"Fighting Ebola: A Window for Vaccine Re-evaluation?","volume":"13","author":"KJ Chappell","year":"2017","journal-title":"PLoS pathogens"},{"key":"pone.0238196.ref005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-med-051215-030919","article-title":"Toward an Effective Ebola Virus Vaccine","volume":"68","author":"R Keshwara","year":"2017","journal-title":"Annual review of medicine"},{"key":"pone.0238196.ref006","first-page":"1","article-title":"Closer than ever to an Ebola virus vaccine","author":"L Banadyga","year":"2017","journal-title":"Expert review of vaccines"},{"key":"pone.0238196.ref007","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/CVI.00003-08","volume":"15","author":"KS Omland","year":"2008","journal-title":"Clinical And Vaccine Immunology"},{"issue":"3","key":"pone.0238196.ref008","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/14760584.2020.1738225","article-title":"The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms","volume":"19","author":"K O\u2019Donnell","year":"2020","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"pone.0238196.ref009","doi-asserted-by":"crossref","first-page":"e0215457","DOI":"10.1371\/journal.pone.0215457","article-title":"Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples","volume":"14","author":"TL Rudge","year":"2019","journal-title":"PLoS ONE"},{"key":"pone.0238196.ref010","first-page":"653","article-title":"RSD and Other Variability Measures of the Lognormal Distribution","volume":"31","author":"CY Tan","journal-title":"Pharmacopeial Forum"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T17:30:43Z","timestamp":1598376643000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238196"}},"subtitle":[],"editor":[{"given":"John","family":"Schieffelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":10,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238196","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]}}}